The Conditas Group Signs Exclusive US Business Development Deal for Medicinal Chemistry and Drug Discovery Services with Melbourne and Shanghai Based Synthesis Med Chem USA for Medicinal Chemistry and Drug Discovery Services

BOSTON--(BUSINESS WIRE)--Conditas Biotechnology Group, LLC, a boutique firm that represents on- and off-shore Contract Research Organizations (CROs) and service providers, connecting them to customers in academia and the biotechnology and pharmaceutical industries, has signed an exclusive agreement with SYN|thesis med chem Pty Ltd.

MORE ON THIS TOPIC